Scott Smith
Smith was appointed Viatris’s CEO due to his strong background in clinical development and commercialization.
Bringing strategic insight and commercial know-how, Smith also has extensive experience in clinical strategy, regulatory affairs, M&A, and global operations.
He is set to implement Viatris’s strategy by managing a focused portfolio of complex generics and branded drugs while supporting new drug development and launches.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.